Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Medical oncology · Sun Yat-sen University Cancer Center · Guangzhou

Dr. Fang Wenfeng方文峰

Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Fang Wenfeng

Professional overview

Dr. Fang Wenfeng is a Chief Physician and Doctoral Supervisor in the Department of Medical Oncology at Sun Yat-sen University Cancer Center, specializing in chemotherapy and targeted therapy for lung cancer, nasopharyngeal carcinoma, and other solid tumors.

SpecialtyMedical oncology
Clinical titleChief Physician
Academic rolesDoctoral Supervisor
DepartmentDepartment of Medical Oncology
HospitalSun Yat-sen University Cancer Center
CityGuangzhou

Areas of focus

Lung cancerFocuses on chemotherapy and targeted therapy for lung cancer, including clinical research on PD-1 monoclonal antibodies and small-molecule targeted drugs.
Nasopharyngeal carcinomaFocuses on chemotherapy and targeted therapy for nasopharyngeal carcinoma, including research on immune escape mechanisms.

Background

  • 2001Bachelor of Clinical Medicine, Wuhan University
  • 2006Second Bachelor's Degree in Life Sciences, Wuhan University
  • 2007Joint training Ph.D. student at University of Illinois at Chicago
  • 2011Ph.D. in Oncology, Wuhan University (integrated master's-doctoral program)
  • 2013Clinical fellowship at University of California, Los Angeles
  • 2015Appointed Associate Chief Physician and Doctoral Supervisor in the Department of Medical Oncology, Sun Yat-sen University Cancer Center

Experience & recognition

  • Principal investigator of National Natural Science Foundation of China (NSFC) Youth Fund project (2012–2015)
  • Principal investigator of Sun Yat-sen University Cancer Center Outstanding Young Talent Fund project (2014–2019)
  • Co-investigator on multiple NSFC and provincial-level research projects related to EGFR-TKI resistance mechanisms in non-small cell lung cancer

Professional roles

  • Chair, Innovation Drug Clinical and Translational Research Professional Committee, Chinese Medical Education Association
  • Standing Committee Member, Non-Small Cell Lung Cancer Society, China Anti-Cancer Association (CACA)
  • Member, Non-Small Cell Lung Cancer Committee, Chinese Society of Clinical Oncology (CSCO)
  • Member, Nasopharyngeal Carcinoma Committee, Chinese Society of Clinical Oncology (CSCO)
  • Chair, Rare and Uncommon Mutation Tumor Professional Committee, China Primary Health Care Foundation
  • Vice Chair, Cell Immunotherapy Professional Committee, China International Exchange and Promotive Association for Medical and Health Care (CPAM)
  • Vice Chair, Guangdong Provincial Society of Nasopharyngeal Carcinoma, Youth Committee
  • Vice Chair, Precision Medicine and Molecular Diagnostics Professional Committee, Guangdong Medical Association

Frequently asked questions

What does Dr. Fang Wenfeng specialize in?

Chemotherapy and targeted therapy for lung cancer, nasopharyngeal carcinoma, and other solid tumors; leading clinical trials of novel anti-tumor agents including PD-1 monoclonal antibodies and small-molecule targeted drugs.

Which hospital and department is Dr. Fang Wenfeng in?

Department of Medical Oncology at Sun Yat-sen University Cancer Center

Sources

Dr. Fang Wenfeng has not reviewed this page.